Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial

计划入组 15 人 · 首次发布于 2014 年 8 月 19 日

Sinopharm-SOBERANA COVID-Cienfuegos

计划入组 202 人

ImmunoTEP for Patients With Medullary Thyroid Carcinoma.

计划入组 25 人 · 首次发布于 2012 年 11 月 21 日

aT19(Immunotech Biopharm Ltd.)

Expanded Activated Lymphocyte(Immunotech Biopharm)

TCR-T(Immunotech Biopharm Ltd.)

AIM ImmunoTech, Inc.

United States

TC BioPharm

United Kingdom

Biopharm SpA

Algeria

Immunotech Biopharm's CAR-T-19 Injection Receives Breakthrough Therapy Designation in China for B-ALL

AIM ImmunoTech Announces Clinical Milestones and Upcoming Studies for Ampligen

AIM ImmunoTech Secures Manufacturing Patent for Ampligen Through 2041